100 results on '"Servent V"'
Search Results
2. Influence of age on the pharmacokinetics of i.v. vinflunine: Results of a phase I trial in elderly cancer patients
3. Results and special considerations when treating elderly patients with CyberKnife ®: A review of 345 cases
4. Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer
5. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
6. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer
7. Chapitre 11 - Oncogériatrie
8. Carcinome canalaire in situ du sein : Analyse de 882 cas
9. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
10. Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients
11. Chapitre 12 - Oncogériatrie
12. Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey
13. Abstract P5-14-08: Adjuvant and neoadjuvant chemotherapy for elderly patients (≥70 years) with early high-risk breast cancer: A retrospective analysis of 116 patients
14. Abstract P2-02-17: T-DM1 in HER2-negative metastatic breast cancer patients with HER2-amplified circulating tumor cells: Current status of the CirCe T-DM1 phase II trial
15. Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†
16. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study
17. Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer
18. Abstract P1-08-34: Is it possible to predict the efficacy of a combination of cetuximab plus docetaxel in patients with operable, triple negative breast cancer (TNBC)? Final biomarker results from a phase II neoadjuvant trial
19. Abstract OT3-3-10: ASTER 70s: Benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial.
20. Abstract P2-13-10: Prospective randomized and multicentric evaluation of cognition in menopausal breast cancer patients receiving adjuvant hormonotherapy: a phase III study (Preliminary results)
21. Vulnerability assessment of the elderly cancer patients: Concordance between screening tests and subjective physician evaluation
22. A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question…
23. Tumor Characteristics, Treatment and Overall Survival (OS) in Breast Cancer Patients (PTS) Over 80 Years: A Cohort From a Single Institution
24. Results and special considerations when treating elderly patients with CyberKnife®: A review of 345 cases
25. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project.
26. STEREOTACTIC RADIOTHERAPY AND ELDERLY PATIENTS
27. Abstract P3-14-11: Trastuzumab Cardiac Toxicity and HER2 Polymorphism: A Case-Control Study
28. Impact of an all-oral capecitabine and vinorelbine combination regimen on functional status of elderly patients with advanced solid tumours: A multicentre pilot study of the French geriatric oncology group (GERICO)
29. Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
30. Nasal septum perforations: A side effect of the association of bevacizumab and taxanes in patients with breast cancer?
31. Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG-PET after the first course.
32. Description des prises en charge des personnes âgées atteintes de cancer dans les établissements de santé bénéficiant de l’unité pilote de coordination en oncogériatrie de Lille
33. Revue de 206 patients traités par CyberKnife® : étude de la faisabilité chez le sujet âgé
34. Feasibility of the sequential FEC 100-Taxotere chemotherapy regimen as an adjuvant or neoadjuvant treatment for breast cancer. Experience of a single institution.
35. Carcinome canalaire in situ du sein. Analyse de 882 cas
36. Preservation of Activities Daily Living (ADL) in a phase-II impact study of oral capecitabine and vinorelbine in the treatment of metastatic carcinomas in patients 70 and older: The GERICO-01 Study by the French FNCLCC Group
37. Ductal carcinoma in situ (DCIS) of the breast: what is the safest treatment?
38. 10-year follow-up update of French adjuvant study group 05 trial: FEC 100 regimen remains superior to FEC 50 in adjuvant chemotherapy of poor prognosis, node-positive, early breast cancer patients
39. Ductal Carcinoma in situ (DCIS) of the breast. Results of conservative surgery without (CS) and with radiotherapy (CS + RT)
40. Ductal carcinoma in situ (DCIS): retrospective analysis of 749 cases
41. Sclérodermie systémique et cancer du sein: deux cas et revue de la littérature
42. A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer.
43. Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancer.
44. Revue de 206 patients traités par CyberKnife ® : étude de la faisabilité chez le sujet âgé
45. A personalized adjuvant treatment for women over 70 presenting with a luminal breast cancer? ASTER 70s or an ongoing phase III trial with parallel cohort by the UNICANCER GERICO and UCBG groups for an ongoing question….
46. Results and special considerations when treating elderly patients with CyberKnife®: A review of 345 cases
47. Prospective randomized and multicentric evaluation of cognition in menopausal breast cancer patients receiving adjuvant hormonotherapy: a phase III study (Preliminary results).
48. Head and neck cancer surgery in the elderly--does age influence the postoperative course?
49. ASTER 70s: Benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial.
50. Revue de 206 patients traités par CyberKnife® : étude de la faisabilité chez le sujet âgé
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.